Carcinoma Causing Thrombotic Thrombocytopenic Purpura and Myelonecrosis: A Very Rare Event

Ilknur Nizam¹, Mehmet Ali Erkurt¹, Ilhami Berber¹, Mustafa Koroglu², Emin Kaya¹, Irfan Kuku¹ and Nese Karadag³

¹Hematology Department, Inonu University Turgut Ozal Medical Center, Malatya, Turkey

²Karabuk University Karabuk Education and Research Hospital, Karabuk, Turkey

³Pathology Department, Inonu University Turgut Ozal Medical Center, Malatya, Turkey

Cite this paper

Ilknur Nizam, Mehmet Ali Erkurt, Ilhami Berber, Mustafa Koroglu, Emin Kaya, Irfan Kuku and Nese Karadag. Carcinoma Causing Thrombotic Thrombocytopenic Purpura and Myelonecrosis: A Very Rare Event. American Journal of Medical Case Reports. 2015; 3(11):372-373. doi: 10.12691/AJMCR-3-11-6

Abstract

We report a case of thrombotic thrombocytopenic purpura (TTP) which was explored to be the clinical presentation of carcinoma. Plasma exchange therapy failed to respond for the patient, so bone marrow aspiration and biopsy were performed to find out the reason of microangiopathic hemolytic anemia. Bone marrow examination revealed non hematopoetic cell infiltration and myelonecrosis. Carcinoma metastasis was demonstrated at bone marrow trephine biopsy. The primary tumor was found at small bowel after scanning for the source of tumor by computerized tomography.

Keywords

TTP, malignancy, plasmapheresis

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Poddar N, Wang JC. Thrombotic thrombocytopenic purpura in a patient with interferon treated hepatitis C successfully treated with rituximab. Hematol Rep. 2013 Jan 25; 5(1): 5-7.
[2]	Vesely SK, George JN, Lammle B, et al. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 2003; 102: 60-8.
[3]	McCrae KR, Sadler JE, Cines D. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. In: Hoffman R, Benz Jr EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, et al., editors. Hematology, basic principles and practice. Philadelphia: Elsevier Churchill Livingstone; 2005. p. 2287-304.
[4]	Koroglu M, Erkurt MA, Berber I, Kuku I, Kaya E, Ozkahraman A, Aydin NE. Primarily unknown origin adenocarcinoma metastasis in bone marrow presenting with thrombotic thrombocytopenic purpura: a case report. Transfus Apher Sci. 2013 Oct; 49(2): 341-4.
[5]	Amorosi EL, Ultmann JE. Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine. 1966; 45: 139-159.
[6]	Eldor Amiram. Thrombotic thrombocytopenic purpura: diagnosis, pathogenesis and modern therapy. Bailliere’s Clin Haematol June 1988;11(2):475-95
[7]	Kwaan HC, Gordon LI. Thrombotic microangiopathy in the cancer patient. Acta Haematol 2001; 106: 52-6.
[8]	Chang JC, Naqvi T. Thrombotic thrombocytopenic purpura associated with bone marrow metastasis and secondary myelofibrosis in cancer. Oncologist 2003; 8: 375-80.
[9]	Kadikoylu G, Barutca S, Tataroglu C, et al. Thrombotic thrombocytopenic purpura as the first manifestation of metastatic adenocarcinoma in a young woman. Trasfus Apher Sci 2010;42(1): 39-42.
[10]	Aksay E, Kiyan S, Ersel M, Hudaverdi O. Thrombotic thrombocytopenic purpura mimicking acute ischemic stroke. Emerg Med J. 2006 Sep; 23(9): e51.
[11]	Gurkan E, Baslamisli F, Guvenc B, et al. Thrombotic thrombocytopenic purpura in southern Turkey: a single-center experience of 29 cases. Clin Lab Haematol 2005; 27: 121-5.